Telgmann Ralph, Brand Eva, Nicaud Viviane, Hagedorn Claudia, Beining Katrin, Schönfelder Jacqueline, Brink-Spalink Verena, Schmidt-Petersen Klaus, Matanis Theodoros, Vischer Peter, Nofer Jerzy-Roch, Hasenkamp Sandra, Plouin Pierre-François, Drouet Ludovic, Cambien François, Paul Martin, Tiret Laurence, Brand-Herrmann Stefan-Martin
Leibniz-Institute for Arteriosclerosis Research, Department of Molecular Genetics of Cardiovascular Disease, University of Münster, Münster, Germany.
J Hypertens. 2007 Mar;25(3):557-64. doi: 10.1097/HJH.0b013e3280144779.
The SAH gene locus has recently been proposed to be involved in obesity-related hypertension in Japanese individuals.
To replicate independently the initial findings in another ethnic group, we scanned the entire SAH gene in 190 Caucasian chromosomes. A total of 651 patients with essential hypertension and 776 controls (PEGASE Study) were genotyped for all identified variants using allele-specific oligonucleotides, and single nucleotide polymorphism as well as haplotype analyses were carried out. We also performed transient transfection experiments, northern and western blots, immunoprecipitation, and acyl-coenzyme A synthetase activity assays.
We identified five polymorphisms in the promoter region (C-1808T, G-1606A, -962ins/del, G-451A, T-67C), two in introns 5 and 7 (T+9/In5C, A+20/In7T), and one missense variant (K359N). Carriage of the -1606A allele was significantly associated with hypertension [odds ratio (OR) 1.28, P = 0.049] as was 359N (OR 1.35, P = 0.048) compared with non-carriers. Conversely, for -962del, the OR for hypertension was 0.80 (P = 0.042). The SAH alleles -1606A and 359N, but not -962ins/del, displayed a raising effect on body mass index (BMI; P = 0.004 and P = 0.030, respectively) in hypertensive as well as in control individuals. After adjustment for BMI in hypertensive individuals, only the OR associated with -962ins/del remained significant (OR 0.77, P = 0.028). Functional analyses in BHK did not reveal differences for SAH 359N or 359K-containing constructs, formally excluding K359N as the functional variant.
We confirm recent evidence that the SAH locus is associated with obesity-related hypertension, in which pathophysiological context SAH variants affecting blood pressure remain, however, to be shown.
最近有研究提出,SAH基因位点可能与日本人群中与肥胖相关的高血压有关。
为了在另一个种族群体中独立重复最初的研究结果,我们对190条白种人染色体上的整个SAH基因进行了扫描。使用等位基因特异性寡核苷酸对总共651例原发性高血压患者和776例对照(PEGASE研究)的所有已鉴定变异进行基因分型,并进行单核苷酸多态性以及单倍型分析。我们还进行了瞬时转染实验、Northern和Western印迹、免疫沉淀以及酰基辅酶A合成酶活性测定。
我们在启动子区域鉴定出5个多态性位点(C-1808T、G-1606A、-962ins/del、G-451A、T-67C),在内含子5和7中鉴定出2个(T+9/In5C、A+20/In7T),以及1个错义变异(K359N)。与非携带者相比,携带-1606A等位基因与高血压显著相关[比值比(OR)1.28,P = 0.049],359N也是如此(OR 1.35,P = 0.048)。相反,对于-962del,高血压的OR为0.80(P = 0.042)。SAH等位基因-1606A和359N,而非-962ins/del,在高血压患者和对照个体中对体重指数(BMI)均有升高作用(分别为P = 0.004和P = 0.030)。在高血压个体中对BMI进行校正后,仅与-962ins/del相关的OR仍具有统计学意义(OR 0.77,P = 0.028)。在BHK细胞中的功能分析未发现含SAH 359N或359K构建体之间存在差异,从而正式排除K359N作为功能变异。
我们证实了最近的证据,即SAH基因位点与肥胖相关的高血压有关,然而,影响血压的SAH变异在何种病理生理背景下发挥作用仍有待阐明。